M&T Bank Corp Makes New $164,000 Investment in National Research Corporation (NASDAQ:NRC)

M&T Bank Corp acquired a new position in shares of National Research Corporation (NASDAQ:NRCFree Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 12,785 shares of the company’s stock, valued at approximately $164,000. M&T Bank Corp owned about 0.06% of National Research as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in NRC. Envestnet Asset Management Inc. lifted its stake in shares of National Research by 23.1% in the 1st quarter. Envestnet Asset Management Inc. now owns 89,985 shares of the company’s stock valued at $1,152,000 after purchasing an additional 16,868 shares during the last quarter. Azzad Asset Management Inc. ADV purchased a new stake in shares of National Research in the 1st quarter valued at $426,000. Willis Investment Counsel raised its holdings in shares of National Research by 19.1% in the 1st quarter. Willis Investment Counsel now owns 65,778 shares of the company’s stock valued at $842,000 after buying an additional 10,531 shares during the period. Rhumbline Advisers raised its holdings in shares of National Research by 4.5% in the 1st quarter. Rhumbline Advisers now owns 22,204 shares of the company’s stock valued at $284,000 after buying an additional 946 shares during the period. Finally, GAMMA Investing LLC raised its holdings in shares of National Research by 45,978.8% in the 1st quarter. GAMMA Investing LLC now owns 15,206 shares of the company’s stock valued at $195,000 after buying an additional 15,173 shares during the period. Institutional investors and hedge funds own 47.26% of the company’s stock.

Insider Activity

In related news, major shareholder Patrick E. Beans acquired 2,500 shares of the firm’s stock in a transaction on Monday, May 12th. The stock was bought at an average cost of $13.59 per share, with a total value of $33,975.00. Following the transaction, the insider owned 35,003 shares of the company’s stock, valued at $475,690.77. The trade was a 7.69% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. 8.10% of the stock is currently owned by company insiders.

National Research Price Performance

Shares of NASDAQ NRC opened at $14.22 on Friday. The stock’s 50-day moving average is $15.30 and its two-hundred day moving average is $14.88. The company has a debt-to-equity ratio of 1.98, a current ratio of 0.54 and a quick ratio of 0.54. National Research Corporation has a 1-year low of $9.76 and a 1-year high of $27.07. The company has a market cap of $323.93 million, a price-to-earnings ratio of 13.81 and a beta of 0.45.

National Research (NASDAQ:NRCGet Free Report) last released its quarterly earnings data on Monday, April 28th. The company reported $0.25 EPS for the quarter. National Research had a return on equity of 71.33% and a net margin of 17.14%. The business had revenue of $33.55 million for the quarter.

National Research Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, July 11th. Investors of record on Friday, June 27th were given a $0.12 dividend. The ex-dividend date was Friday, June 27th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 3.38%. National Research’s dividend payout ratio (DPR) is presently 46.60%.

National Research Profile

(Free Report)

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.

Further Reading

Want to see what other hedge funds are holding NRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Research Corporation (NASDAQ:NRCFree Report).

Institutional Ownership by Quarter for National Research (NASDAQ:NRC)

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.